|
Market Closed -
Australian S.E.
03:59:54 20/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 0.9950 AUD | -3.86% |
|
-4.33% | +136.90% |
| Market Cap | 238M 166M 148M 137M 125M 235M 15.78B 1.65B 648M 8.25B 625M 611M 26.37B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 234M 163M 145M 135M 122M 230M 15.46B 1.62B 635M 8.08B 612M 599M 25.83B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
41.81% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Deutsche Boerse AG
| PR80 | Delayed | |
|
Boerse Muenchen
| PR80 | Real-time |
Last Transcript: BLS Pharmaceuticals Limited
| 1 day | -3.86% | ||
| 1 week | -4.33% | ||
| Current month | -5.24% | ||
| 1 month | -17.43% | ||
| 3 months | +11.80% | ||
| 6 months | +29.22% | ||
| Current year | +136.90% |
| 1 week | 0.96 |  | 1.13 |
| 1 month | 0.94 | | 1.27 |
| Current year | 0.36 | | 1.3 |
| 1 year | 0.35 | | 1.3 |
| 3 years | 0.04 | | 1.3 |
| 5 years | 0.04 | | 1.3 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 19/05/2023 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 01/09/2016 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 05/12/2012 |
Guy Robertson
BRD | Director/Board Member | 72 | 30/06/2022 |
Sam Watson
BRD | Director/Board Member | - | 19/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/5/26 | Buy | 5,000,000 | 0.2202% | |||
| 14/5/26 | Exercice | 5,000,000 | 0.2202% | |||
| 22/3/26 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.86% | -4.33% | +168.92% | +804.55% | 166M | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | |
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | |
| -0.40% | +3.53% | +19.17% | +46.55% | 286B | |
| -0.37% | +3.11% | -1.26% | +18.23% | 256B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | |
| Average | -1.27% | +2.11% | +46.60% | +138.91% | 390.03B | |
| Weighted average by Cap. | -0.98% | +2.30% | +37.85% | +75.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 20.45M 18.23M 16.88M 15.35M 28.81M 1.94B 203M 79.63M 1.01B 76.72M 75.11M 3.24B | 73.91M 51.61M 46.01M 42.62M 38.75M 72.71M 4.89B 511M 201M 2.56B 194M 190M 8.18B |
| Net income | 4.9M 3.42M 3.05M 2.83M 2.57M 4.82M 324M 33.9M 13.33M 170M 12.84M 12.57M 542M | 15.4M 10.75M 9.58M 8.88M 8.07M 15.15M 1.02B 106M 41.87M 533M 40.34M 39.5M 1.7B |
| Net Debt | -6.13M -4.28M -3.82M -3.54M -3.22M -6.03M -406M -42.43M -16.68M -212M -16.07M -15.74M -679M | -4.86M -3.39M -3.02M -2.8M -2.55M -4.78M -321M -33.58M -13.21M -168M -12.72M -12.46M -537M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/10/26 | $0.9950 | -3.86% | 409,810 |
| 19/10/26 | $1.035 | -6.76% | 535,084 |
| 16/10/26 | $1.110 | +2.30% | 248,383 |
| 15/10/26 | $1.085 | 0.00% | 592,164 |
| 14/10/26 | $1.085 | +4.33% | 416,857 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
